Zydus Cadila begins enrolment for Phase 3 vaccine trial: Reports
India Published: Friday, January 22, 2021, 11:37 [IST]
New Delhi, Jan 22: Zydus Cadila has started enrolling and dosing participants in India for the Phase 3 clinical trial of its three-dose COVID-19 vaccine ZyCoV-D, according to reports.
The trials are expected to take place across four cities - Surat, Nashik, Jaipur and Ahmedabad.
Representational Image
Zydus Cadila received DCGI s approval earlier this month to initiate Phase 3 trials in 26,000 Indian participants. We started enrolment and dosing of participants from Saturday. The enrolment and dosing happens between 9am and 5pm, the principal investigator at a trial site, one of the two people mentioned above, said on condition of anonymity.